Introduction ALPCO developed STELLUX® as a chemiluminescent immunoassay platform aimed at detecting key biomarkers in the life science research and Read More…
Introduction Bones are traditionally known for their support, protection and movement properties, as well as their role in the processes Read More…
Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease in the western hemisphere affecting 1 in Read More…
Obesity is a known risk factor for developing metabolic diseases such as non-alcoholic fatty liver disease (NAFLD)1. An increasing amount Read More…
Monoclonal antibody (mAb) biologics have been used to treat inflammatory bowel disease (IBD) for several years. Various classes of biologics Read More…
Multiple classes of biologics are available for the treatment of inflammation associated with inflammatory bowel disease (IBD) which ultimately improves Read More…
Anti-TNF-alpha biologics have been proven to be effective treatments for autoimmune diseases such as rheumatoid arthritis (RA) and inflammatory bowel Read More…
Monoclonal antibody (mAbs) biologics have been used to treat inflammatory bowel disease (IBD) for 20 years1. Despite the successful use Read More…
Active glucagon-like peptide-1 (GLP-1) is a member of the incretin hormone family and is generated as a result of post Read More…
Glucagon is a gut hormone generated as a result of post translational modifications during proglucagon processing in the pancreas1,2,3. Research Read More…
The combination of blocking peptide and Mass spectrometry (MS) It is reported that the annual loss in biological and Read More…
Who are we? Affinity Biotech was founded in 2006 and our domestic base was put into use in 2012. Our Read More…